publication date: Mar. 8, 2019

Funding Opportunities

FDA Oncology Center of Excellence publishes research contract opportunities

The FDA Oncology Center of Excellence seeks white papers to award contracts for oncology regulatory science research through a Broad Agency Announcement, FDABAA-19-00123.

Research areas are described in the BAA document, but specific OCE interests include analysis of symptoms, physical function, immunotherapy biomarkers, non-clinical studies to evaluate new targeted therapies in children, real-world data endpoints, and external controls for pediatric studies.

Submit quad charts and whitepapers to FDABAA@fda.hhs.gov by March 30.

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.